Insider Trading History of Rawcliffe Adrian

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Rawcliffe Adrian since 2018. This trader's CIK number is 1555851. At the time of last reporting, Rawcliffe Adrian was the Officer of Wave Life Sciences Ltd.. (stock ticker symbol WVE). Also see all insider trading activities at Wave Life Sciences Ltd..

Note that in the past Rawcliffe Adrian also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Wave Life Sciences Ltd. (WVE) by Rawcliffe Adrian

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 WVE 0 $0 16,115 $109,420 0 $0

Yearly summary of insider trading at Adaptimmune Therapeutics Plc (ADAP) by Rawcliffe Adrian

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ADAP 0 $0 90,170 $52,427 0 $0
2024 ADAP 0 $0 68,586 $52,327 0 $0
2023 ADAP 0 $0 51,671 $86,091 0 $0
2022 ADAP 0 $0 39,134 $128,949 0 $0
2021 ADAP 0 $0 23,129 $125,791 0 $0
2020 ADAP 0 $0 14,700 $73,122 0 $0
2019 ADAP 0 $0 3,084 $16,557 0 $0
2018 ADAP 0 $0 600,000 $1,026,000 0 $0


Insider trading activities at 2 companies by Rawcliffe Adrian:

1. Wave Life Sciences Ltd. (WVE)

2. Adaptimmune Therapeutics Plc (ADAP)

Table 1. Insider trading of Wave Life Sciences Ltd. (WVE) by Rawcliffe Adrian

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-11-13 WVE Sale 16,115 6.79 109,420

Table 2. Insider trading of Adaptimmune Therapeutics Plc (ADAP) by Rawcliffe Adrian

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-01-17 ADAP Sale 30,601 .58 17,779
2025-01-13 ADAP Sale 30,473 .59 17,918
2025-01-15 ADAP Sale 29,096 .57 16,730
2024-01-16 ADAP Sale 9,304 .79 7,350
2024-01-17 ADAP Sale 30,080 .67 20,243
2024-01-12 ADAP Sale 17,257 .85 14,737
2024-01-11 ADAP Sale 11,945 .84 9,997
2023-09-01 ADAP Sale 2,403 .78 1,874
2023-06-27 ADAP Sale 2,333 .92 2,146
2023-01-17 ADAP Sale 10,057 1.86 18,685
2023-01-11 ADAP Sale 13,042 1.75 22,784
2023-01-12 ADAP Sale 18,763 1.71 32,009
2023-01-04 ADAP Sale 5,073 1.69 8,593
2022-09-01 ADAP Sale 2,536 1.97 4,993
2022-06-27 ADAP Sale 2,562 1.63 4,176
2022-01-18 ADAP Sale 11,096 3.19 35,418
2022-01-11 ADAP Sale 14,362 3.56 51,085
2022-01-12 ADAP Sale 3,046 3.54 10,795
2022-01-04 ADAP Sale 5,532 4.06 22,482
2021-09-01 ADAP] Sale 2,782 5.20 14,452
2021-06-28 ADAP Sale 2,794 4.37 12,209
2021-01-19 ADAP Sale 9,879 5.67 56,013
2021-01-12 ADAP Sale 2,707 6.15 16,653
2021-01-04 ADAP Sale 4,967 5.33 26,464
2020-09-01 ADAP Sale 2,776 8.52 23,637
2020-08-03 ADAP Sale 2,788 9.25 25,789
2020-01-14 ADAP Sale 3,236 5.13 16,616
2020-01-06 ADAP Sale 5,900 1.20 7,080
2019-01-14 ADAP Sale 3,084 5.37 16,557
2018-03-20 ADAP Sale 600,000 1.71 1,026,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rawcliffe Adrian (Officer of Wave Life Sciences Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.